title: [A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder].
abstract: We report a case of percutaneous bacillus Calmette-Guérin (BCG) perfusion therapy for carcinoma in situ (CIS) of upper urinary tract after radical cystectomy with ileal neobladder. A 42-year-old man underwent radical cystectomy and ileal neobladder diversion due to the recurrence of CIS in prostatic urethra after transurethral resection of bladder tumor 3 times and 2 courses of intravesical BCG therapy. Final pathological findings showed the presence of CIS in the right distal ureteral margin. After the radical cystectomy, our diagnosis was CIS in the right residual ureter, because of positive urine cytology and negative radiographic findings in the upper urinary tract. We performed the percutaneous BCG perfusion therapy for CIS of the right upper urinary tract after the construction of the percutaneous nephrostomy by intentionally inducing hydronephrosis. No recurrence was found after 3 years of BCG perfusion therapy.
authors.affiliation: The Department of Urology, Jikei University.
authors.forename: Koki
authors.initials: K
authors.lastname: Obayashi
authors.affiliation: The Department of Urolog, Jikei University Kashiwa Hospital.
authors.forename: Jun
authors.initials: J
authors.lastname: Miki
authors.affiliation: The Department of Urology, Jikei University.
authors.forename: Kanako
authors.initials: K
authors.lastname: Kasai
authors.affiliation: The Department of Urology, Jikei University.
authors.forename: Kojiro
authors.initials: K
authors.lastname: Tashiro
authors.affiliation: The Department of Urolog, Jikei University Kashiwa Hospital.
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Tsuduki
authors.affiliation: The Department of Urolog, Jikei University Kashiwa Hospital.
authors.forename: Shigehiro
authors.initials: S
authors.lastname: Bando
authors.affiliation: The Department of Urology, JR Tokyo General Hospital.
authors.forename: Gen
authors.initials: G
authors.lastname: Ishii
authors.affiliation: The Department of Urology, Jikei University Katsushika Medical Center.
authors.forename: Kan
authors.initials: K
authors.lastname: Suzuki
authors.affiliation: The Department of Urology, Jikei University.
authors.forename: Takahiro
authors.initials: T
authors.lastname: Kimura
authors.affiliation: The Department of Urolog, Jikei University Kashiwa Hospital.
authors.forename: Koichiro
authors.initials: K
authors.lastname: Kishimoto
authors.affiliation: The Department of Urology, Jikei University.
authors.forename: Sin
authors.initials: S
authors.lastname: Egawa
mesh_terms: D000328:Adult; D001500:BCG Vaccine / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000601:surgery; D015653:Cystectomy; D006801:Humans; D007082:Ileum / Q000601:surgery*; D008297:Male; D014523:Urethral Neoplasms / Q000188:drug therapy* / Q000601:surgery; D001743:Urinary Bladder / Q000601:surgery*
chemical_list: D001500:BCG Vaccine